Antigenics News

News on Antigenics (Ticker: AGEN) continually updated from thousands of sources around the net.

Wednesday Feb 8 | AmericanBankingNews.com

Agenus (AGEN) Posts Large Volume Increase, 301,000 Shares Trade Hands.

The stock last traded at $3.47, up from its previous close of $2.93. Separately, analysts at William Blair initiated coverage on shares of Agenus in a research note to investors on Wednesday, January 4th.

Comment?

Mon Feb 06, 2012

BioSpace

Agenus (Formerly known as Antigenics Inc. - Lexington, MA) to Present ...

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Agenus to Present at Biotechnology Industry Organization CEO & Investor Conference LEXINGTON, Mass., Feb.

Comment?

Related Topix: Biotech, Healthcare Industry, Lexington, MA

GlobeNewswire

Agenus to Present at Bio Ceo & Investor Conference

Agenus Inc. , a developer of therapeutic vaccines for cancer and infectious diseases, today announced that the company will be presenting at the 14th Annual BIO CEO & Investor Conference, which will be held at the Waldorf=Astoria Hotel in New York City.

Comment?

Fri Jan 20, 2012

Electric Energy Online

American DG Energy Directors Elect New Board Member

Waltham, MA, January 20, 2012 - American DG Energy Inc. , a leading OnSite Utility, offering clean electricity, heat, hot water and cooling solutions to hospitality, healthcare, housing and athletic facilities, announced that Christine M. Klaskin, was elected to the Company's Board of Directors and is a member of the Audit Committee.

Comment?